GNoME (2.2M structures), MatterGen MIT-licensed, ARPA-E CATALCHEM-E + DARPA Crystal Palace all presume more candidates = upstream value.
Discovery-platform valuations compress 60–80%. Capital rotates out of generative-model labs and into integrators with synthesis + cert relationships.
2026–2027 capital-call cycle for the Periodic / Lila / CuspAI cohort. Series-C reality without commercial volume forces a public re-rating. Matter Loop must be in position as "destination of distressed capital + distressed IP" by then.